تدريــس الأمـم المتحدة

Trimetazidine Dihydrochloride is a well-established anti-anginal agent used in the management of ischemic heart disease. It improves myocardial glucose utilization through inhibition of fatty acid metabolism, enhancing cardiac efficiency.

Salius Pharma supplies high-purity Trimetazidine API manufactured under GMP-compliant conditions and available in USP and EP grades. Regulatory documentation such as DMF and COA is available upon request.

Applications:
Used in the formulation of oral tablets to treat angina pectoris, especially as an add-on therapy in cardiovascular treatment plans.